Ark Genomic Revolution ETF (ARKG)
$29.19
0.94 (3.33%)
ARKG Stock Quote Delayed 30 Minutes
11 Best Stocks to Buy for 2023
INSIDE: Investing legend Louis Navellier reveals his Top 11 Stocks for 2023 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
18.59M
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
926,855
Day's Range
$28.27 - $29.33
52-Week Range
$21.97 - $38.97
Dividend & Yield
N/A (N/A)
ARKG Stock Predictions, Articles, and Ark Genomic Revolution ETF News
Cathie Wood Is Buying Up Red-Hot Invitae (NVTA) Stock
Shares of NVTA stock closed higher by about 240% yesterday. Cathie Wood's Ark Invest reported purchasing shares prior to earnings.
ARK Invest Buys: What Stocks Is Cathie Wood Buying on the Dip This Week?
ARK Invest buys this week have some stocks taking off as the private investment firm picks up shares on the stock market dip.
ARK Innovation ETF Is Worth Owning as Long as the Bull Market Continues
The ARKK ETF has been one of the biggest winners over the past five years. It should continue to prosper, at least until the current tech boom fades.
Ark Invest Funds: Why ARKG, ARKF, ARKQ and the ARKK ETF Are Stumbling
Ark Invest funds like the ARKK ETF are falling today thanks to big bets on Tesla and Bitcoin. Here's why the big picture is still bright.
How to Find the Top Stocks in the Hottest Sectors
Here's how a sector fund can help you find top stocks in sizzling sectors. They’re a great place to start, especially when you want to gain exposure to a specific hypergrowth trend.
3 of the Best Biotech ETFs on the Market
The fourth quarter has been a different story. IBB, the largest biotech ETF by assets, is up 16.65% since Oct. 1, pushing its year-to-date gain to 26.57% as of Dec. 20. That after months of investors pulling money from actively managed biotech funds, but that situation is starting to correct as well as data out this month indicate investors are warming to biotech assets again.
7 Biotech ETFs That Should Remain Healthy
The healthcare sector has been the worst performing on the S&P 500 in 2019, but these biotech ETFs are still worth a look.
